Bristol-Myers Squibb Company
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $47.60B | $16.34B | $10.35B |
| FY2025 | $42.85B | $18.47B | $10.21B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $47.60B | $16.34B | $10.35B |
| FY2025 | $42.85B | $18.47B | $10.21B |